First International PTCOG Ocular Proton Therapy Symposium 2022
→
Europe/Zurich
Description
Dear colleagues,
We warmly welcome you to the virtual platform for the First International PTCOG Ocular Proton Therapy Symposium 2022.
We are pleased to present thirty-six international experts from radiation oncology, ophthalmology, and radiology to speak on advanced current techniques and future directions for ocular proton/particle radiotherapy.
Recordings of the symposium presentations are now available at our youtube channel.
Working Group responsible for the Symposium preparation
Jan Hrbacek, PhD (PSI, Switzerland), Co-Chair
Andrzej Kacperek, Prof, PhD (UCL, UK), Co-Chair
Kavita K. Mishra, MD MPH (UCSF, USA), Co-Chair
Jan-Willem Beenakker, PhD (LUMC, Netherlands)
Remi Dendale, MD (Institut Curie, France)
Andrea Denker, PhD (HZB, Germany)
Jens Heufelder, PhD (Charité, Germany)
Alejandro Mazal, PhD (CPQ, Spain)
Linda Mortimer, PhD (CCC, UK)
Helen Shih, MD (MGH, USA)
Roelf Slopsema, MSc (Emory, USA)
Contact person
Registration
Registration form
258
/ 270
Participants
258
View full list
-
-
Welcome
-
“State of the Art” Treatment Outcomes & Critical Structure DosimetryConvener: Helen Shih (Massachusetts General Hospital)
-
14:10
Introduction to the session “State of the Art” Treatment Outcomes & Critical Structure Dosimetry
-
1
Clinical audit of different radiation modalities and different proton beams for ocular tumorsSpeaker: Juliette Thariat
-
2
Ocular late effects in long term survivors of uveal melanoma in adult and AYA patients treated by proton therapySpeaker: Alessia Pica (PSI - Paul Scherrer Institut)
-
3
Management of ocular side effects following proton beam radiotherapy for uveal melanomaSpeaker: Heinrich Heimann
-
4
Navigating Change and Improving Outcomes: Patient-Centered Strategies for the Next DecadeSpeaker: Kavita K. Mishra (University of California San Francisco)
-
14:50
Discussion
-
14:10
-
15:00
Break
-
Ophthalmologist PerspectivesConvener: Kavita K. Mishra (University of California San Francisco)
-
15:10
Introduction to the session Ophthalmologist Perspectives
-
5
Ophthalmic advances in proton beam radiotherapy for ocular tumoursSpeaker: Bertil Damato
-
6
Surgical experience and RT toxicity with a dedicated ocular beamline: Orsay experienceSpeaker: Nathalie Cassoux
-
7
Best practices from the Chicago Proton Center gantry set-up: Opportunities and ChallengesSpeaker: Rashmi Kapur
-
8
Surgical best practices and potential pitfalls for proton ocular RT: An ophthalmologist perspectiveSpeaker: Ann Schalenbourg
-
15:50
Discussion
-
15:10
-
16:10
Break
-
Dedicated Ocular Beamline & Universal Beamlines Adapted for Ocular TherapyConvener: Andrzej Kacperek (University College London)
-
9
Delivery of optimal ocular proton beams in the next decade?Speaker: Andrzej Kacperek (University College London)
-
10
The long-term Nice experience with a dedicated proton eyeline: what can we change without compromising clinical outcomes?Speaker: Joël Hérault (IMPT-Centre Antoine Lacassagne)
-
11
Treating ocular melanoma with a modified pencil-beam-scanning system: a dosimetric studySpeaker: roelf slopsema (Emory University)
-
12
Characterization of the non-dedicated scanning proton beamline for ocular treatment and clinical workflow at CNAOSpeaker: MARIO CIOCCA (Fondazione CNAO)
-
13
First experience in the Netherlands: Workflow, characterization and multicenter comparison of the HollandPTC ocular beamlineSpeaker: Kees Spruijt
-
17:10
Break
-
14
Commissioning a commercial eye treatment solution - experience at WPESpeaker: Benjamin Koska (WPE)
-
15
Implementation of Gantry-Based Treatment at the Mayo Clinic: brass-free and auto-gatedSpeaker: Amanda Deisher (Mayo Clinic - Rochester)
-
16
3-D planning and multi-field treatment without using an ocular beamlineSpeaker: William Hartsell (Northwestern Medicine Proton Center)
-
17:48
Round Table Discussion, Future outlook, Q&A
-
18:20
Ocular Proton Therapy Centers Survey 2022
-
9
-
-
-
2D & 3D Imaging for Treatment PlanningConvener: Jens Heufelder
-
14:00
Introduction to the session 2D & 3D Imaging for Treatment Planning
-
17
High resolution MR-imaging for ocular proton therapy planningSpeaker: Jan-Willem Beenakker (Leiden University Medical Center)
-
18
MRI evaluation for proton beam treatment planningSpeaker: Berit Verbist (Leiden University Medical Centre)
-
19
Strengths and weaknesses of different imaging modalities, an ophthalmologists perspective with focus on treatment planningSpeaker: Antonia Joussen
-
20
From clip-based to clipless treatmentSpeaker: Jan Hrbacek (PSI - Paul Scherrer Institut)
-
14:40
Discussion
-
14:00
-
14:50
Break
-
Ocular Treatment Planning Systems Current State and DevelopmentConvener: Mr Jan Hrbacek (PSI - Paul Scherrer Institut)
-
15:00
Introduction to the session Ocular Treatment Planning Systems Current State and Development
-
21
EYEPLAN for Proton Radiation Therapy of Ocular Melanoma: UCSF ExperienceSpeaker: Inder Daftari (University of California- San Francisco)
-
22
From EyePlan to Octopus: From model based to 3D planningSpeaker: Jens Heufelder
-
23
Experience with the RayOcular TPS – from initial requirements to treated patients at WPESpeaker: Jörg Wulff
-
24
Planning Eye Treatments in a Spot Scanning Gantry with Monte Carlo Calculated BeamletsSpeaker: Jon Kruse
-
25
Treatment planning systems for ocular treatment with carbon-ion beamsSpeaker: Nobuyuki Kanematsu (National Institutes for Quantum Science and Technology)
-
15:49
Discussion
-
15:00
-
16:00
Break
-
Patient Set-Up/Delivery and Challenging CasesConvener: Alejandro Mazal
-
16:10
Introduction to the session Patient Set-Up/Delivery and Challenging Cases
-
26
Overview of patient set-up and delivery with tipsSpeaker: Helen Shih (Massachusetts General Hospital)
-
27
A challenging case of a large conjunctival squamous cell carcinomaSpeaker: Roi Dagan
-
28
CT based simulation utilizing MRI and scleral clipsSpeaker: Lia Halasz (University of Washington)
-
29
Proton Re-irradiation for Choroidal MelanomasSpeaker: remi Dendale (INSTITUT CURIE ORSAY)
-
30
Eye Tracking technologies for positioning and motion management in Ocular Proton TherapySpeaker: Riccardo Via (PSI - Paul Scherrer Institut)
-
16:59
Discussion
-
16:10
-
17:10
Break
-
Dosimetry & QAConvener: roelf slopsema (Emory University)
-
17:20
Introduction to the session Dosimetry & QA
-
31
Spatially fractionated proton therapy for eye cancer - Feasibility studySpeaker: Jan Swakon
-
32
QA of ocular treatments at Massachusetts GeneralSpeaker: Alexei Trofimov (Massachusetts General Hospital)
-
33
In-house developed tools for QA of dedicated ocular beam lineSpeaker: Jessica Scholey (University of California San Francisco)
-
34
Aspects of the Ocular Quality Assurance Program at the Centre de Protonthérapie d’OrsaySpeaker: Catherine Nauraye
- 35
-
18:09
Discussion
-
17:20
-
Future Directions
-